Sfondo Header
L'angolo del dottorino
Search the site... Advanced search
✖

Mitral valve prolapse:
is it dangerous?

In most people, mitral valve prolapse is not a dangerous condition. Many cases are discovered incidentally and remain stable for years, especially when the valve allows only a small amount of blood to leak backward and there are no major changes in the heart or significant arrhythmias.
Prolapse, however, is not the same in everyone. In some patients it can cause progressively more significant mitral regurgitation; in a much smaller subgroup it can be associated with ventricular arrhythmias that require specific assessment.

For the anatomy, diagnosis and complete classification, see the monograph on mitral valve prolapse. This guide instead answers the practical question: when prolapse is mainly a finding to monitor and when it deserves greater attention.

When mitral valve prolapse is generally low risk

Mitral valve prolapse is relatively common in the general population. If the echocardiogram shows a prolapsing valve but mitral regurgitation is absent or mild, the left ventricle and left atrium are normal and there are no significant symptoms or arrhythmias, the course is generally favorable.
In this situation there is no indication for invasive treatment simply because a valve leaflet prolapses. The main point is follow-up, with its frequency determined according to the severity of regurgitation and individual characteristics.

The presence of a click or murmur on auscultation also does not determine risk by itself. The overall combination of echocardiographic findings, symptoms, heart rhythm and changes over time defines the situation.

The most common problem: when the valve starts leaking significantly

The most clinically important complication of prolapse is mitral regurgitation. If one or both leaflets do not close properly, some blood flows back into the left atrium during ventricular contraction. In mild cases this may have minimal consequences; if regurgitation becomes severe, the heart can progressively enlarge and shortness of breath, reduced exercise capacity or atrial fibrillation may develop.
The amount of regurgitation and its consequences are assessed by echocardiography, not by symptom intensity alone.

When regurgitation becomes severe, management follows the criteria for mitral regurgitation. In many patients with degenerative prolapse and favorable anatomy, if intervention is required, surgical valve repair is preferred to replacement when a durable result is expected.

Palpitations and arrhythmias: when further assessment is needed

Palpitations are common and do not automatically mean that the prolapse is dangerous. They may correspond to isolated premature beats, supraventricular tachycardias or even heightened awareness of normal heartbeats. If they are persistent or associated with other warning signs, prolonged electrocardiographic monitoring can document what is actually happening.
Particular attention is warranted for unexplained syncope, episodes of ventricular tachycardia, very frequent or complex premature ventricular beats, and specific electrocardiographic or imaging abnormalities.

The international consensus on arrhythmic mitral valve prolapse emphasizes that risk should be assessed by combining clinical history, ECG, rhythm monitoring, echocardiography and, in selected cases, cardiac magnetic resonance imaging. The vast majority of people with prolapse do not belong to the high-risk group.

Mitral annular disjunction: what it really means

Mitral annular disjunction is a particular anatomical separation between the mitral valve junction and the left ventricular myocardium. It may be seen together with prolapse and is one of the features studied in the so-called arrhythmic phenotype.
Finding it in a report does not, however, mean that a serious arrhythmia will occur. Its importance changes depending on whether other factors are present, such as documented arrhythmias, syncope, markedly redundant leaflets, ECG abnormalities or fibrosis on magnetic resonance imaging.

It is therefore useful to avoid two extremes: completely ignoring the finding or interpreting it as a high-risk diagnosis regardless of everything else. Assessment is always comprehensive.

Which follow-up tests are needed and which symptoms should be reported

The main follow-up test is an echocardiogram, with longer or shorter intervals according to the amount of mitral regurgitation and the size of the cardiac chambers. If there are significant palpitations, syncope, frequent premature beats or other concerns, the cardiologist may add Holter monitoring or longer-duration monitoring.
Magnetic resonance imaging is not necessary for every prolapse, but it may be useful in patients in whom the ventricle, mitral apparatus and presence of fibrosis need to be better characterized.

Assessment should be brought forward if new shortness of breath, reduced exercise capacity, persistent palpitations, syncope or presyncope develops. Treatment depends on the cause of the problem: managing severe mitral regurgitation is one issue, while documenting and treating a clinically significant arrhythmia is another.

Frequently asked questions about mitral valve prolapse

Is mitral valve prolapse a serious disease?
In most people, no, especially if regurgitation is minimal and there are no major arrhythmias or changes in the cardiac chambers.

Can it cause sudden death?
The risk in the general population with prolapse is low. There is, however, a small subgroup with features that require more detailed arrhythmic assessment.

Are palpitations dangerous?
Not necessarily. They should be documented if they are frequent, new or associated with fainting or other warning signs.

What is mitral annular disjunction?
It is a particular anatomical configuration of the mitral annulus. By itself it does not imply an unfavorable prognosis and is interpreted together with the other clinical and instrumental findings.

How often should prolapse be checked?
It depends mainly on the severity of mitral regurgitation, the size of the heart and whether symptoms or arrhythmias are present.

Bibliography
  1. Praz F, Borger MA, Lanz J, et al. 2025 ESC/EACTS Guidelines for the management of valvular heart disease. European Heart Journal. 2025;46(44):4635-4736. doi:10.1093/eurheartj/ehaf194.
  2. Sabbag A, Essayagh B, Barrera JDR, et al. EHRA expert consensus statement on arrhythmic mitral valve prolapse and mitral annular disjunction complex. Europace. 2022;24(12):1981-2003. doi:10.1093/europace/euac125.
  3. Freed LA, Levy D, Levine RA, et al. Prevalence and Clinical Outcome of Mitral-Valve Prolapse. New England Journal of Medicine. 1999;341(1):1-7. doi:10.1056/NEJM199907013410101.
  4. Avierinos JF, Gersh BJ, Melton LJ 3rd, et al. Natural History of Asymptomatic Mitral Valve Prolapse in the Community. Circulation. 2002;106(11):1355-1361. doi:10.1161/01.CIR.0000028933.34260.09.
  5. Basso C, Perazzolo Marra M, Rizzo S, et al. Arrhythmic Mitral Valve Prolapse and Sudden Cardiac Death. Circulation. 2015;132(7):556-566. doi:10.1161/CIRCULATIONAHA.115.016291.
  6. Essayagh B, Sabbag A, Antoine C, et al. Presentation and Outcome of Arrhythmic Mitral Valve Prolapse. Journal of the American College of Cardiology. 2020;76(6):637-649. doi:10.1016/j.jacc.2020.06.029.
  7. Zoghbi WA, Adams D, Bonow RO, et al. Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation. Journal of the American Society of Echocardiography. 2017;30(4):303-371. doi:10.1016/j.echo.2017.01.007.
  8. Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease. Circulation. 2021;143(5):e72-e227. doi:10.1161/CIR.0000000000000923.
  9. Basso C, Perazzolo Marra M. Mitral Annulus Disjunction: Emerging Role of Myocardial Mechanical Stretch in Arrhythmogenesis. Journal of the American College of Cardiology. 2018;72(14):1610-1612. doi:10.1016/j.jacc.2018.07.069.
  10. Delling FN, Vasan RS. Epidemiology and Pathophysiology of Mitral Valve Prolapse: New Insights Into Disease Progression, Genetics, and Molecular Basis. Circulation. 2014;129(21):2158-2170. doi:10.1161/CIRCULATIONAHA.113.006702.

Informational notice: the information contained on this page is provided solely for informational and educational purposes and does not replace the advice, diagnosis or treatment provided by a physician. If needed, always consult a qualified healthcare professional.

Artificial intelligence transparency: this page was created with the support of artificial intelligence tools, used to assist in the production and processing of its content.